We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
AMRI, Proteros Crystallize Pact
News

AMRI, Proteros Crystallize Pact

AMRI, Proteros Crystallize Pact
News

AMRI, Proteros Crystallize Pact

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "AMRI, Proteros Crystallize Pact"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

AMRI and Proteros Biostructures have signed an agreement for a joint offering to the life sciences industry. Proteros will provide protein crystallization and X-ray structural analysis services that complement AMRI’s existing drug discovery capabilities in chemistry, in vitro biology, drug metabolism and pharmacokinetics services.

According to a joint statement, "Proteros’ expertise in structural biology services combined with AMRI’s expansive discovery and development capabilities provides biotechnology and pharmaceutical companies access to a portfolio of contract services from two companies known for their high level of expertise, dedication to quality and impressive track record of success."

“We are excited about this new relationship that expands the depth and level of service we can offer to customers around the globe looking for integrated solutions from one point of service and contact,” said Thomas E. D’Ambra, Ph.D., AMRI's chairman, president and chief executive officer.

Advertisement